A phase IB, open-label dose-escalating study of the oral angiogenesis inhibitor PTK787/ZK 222584 (PTK/ZK), in combination with FOLFOX4 chemotherapy in patients with advanced colorectal cancer (Q79546010)
Jump to navigation
Jump to search
scientific article published on 11 January 2007
Language | Label | Description | Also known as |
---|---|---|---|
English | A phase IB, open-label dose-escalating study of the oral angiogenesis inhibitor PTK787/ZK 222584 (PTK/ZK), in combination with FOLFOX4 chemotherapy in patients with advanced colorectal cancer |
scientific article published on 11 January 2007 |
Statements
A phase IB, open-label dose-escalating study of the oral angiogenesis inhibitor PTK787/ZK 222584 (PTK/ZK), in combination with FOLFOX4 chemotherapy in patients with advanced colorectal cancer (English)
A L Thomas
C Bartel
D Laurent
A Henry
M Poethig
J Wang
E Masson
W Steward
U Vanhoefer
11 January 2007